Sir,

Prophylactic anticoagulant therapies in the form of warfarin, clopidogrel or aspirin are commonly prescribed for patients who are at risk of thromboembolism. Examples of such patients include those with mechanical heart valves, chronic atrial fibrillation, a past history of venous thromboembolism and those thought to be at cardiac risk. Such patients requiring surgery can pose a challenge, as one has to weigh the risk of bleeding-related complications against the elevated risks of a potentially fatal thrombotic episode occurring should anticoagulants be halted for surgery. Despite existing literature exemplifying a low risk of peri-operative bleeding in dental, eye, joint, endoscopic procedures\[[@ref1]\] and authors advocating no interruption of the anti-thrombotic therapy in such surgeries (provided patients' *international normalized ratio* \[INR\] are within normal therapeutic range), there still exist no clear guidelines or data to define this risk in hand surgery.\[[@ref2]\] Anecdotally, it is still common practice in many units to stop anticoagulation therapy prior to hand surgery based mainly on surgeon preference. Wallace *et al*.\[[@ref3]\] have described that they, as early as 1996, had been performing hand surgeries without altering the patient\'s anticoagulant regimen, as long as the INR was \<3. Retrospective analysis of all his patients who underwent surgery from 1996 to 2003 portrayed that there were no additional days of stay related to bleeding complications. In the same year, Smit and Hooper\[[@ref2]\] arrived at a similar conclusion after reviewing the records of their patients who underwent surgery either for carpal tunnel release or Dupuytren\'s contracture. Of the 852 procedures carried out, 22 patients were found to be on warfarin and despite not stopping or altering therapy, no peri or post-operative bleeding was reported. More recently, two prospective studies concurred that the continuation of anticoagulation for hand surgery is safe.\[[@ref4][@ref5]\] As described by Nandoe Tewarie and Bartels, of the 52 patients (out of 364) on anticoagulants, only one patient, who was on aspirin developed postoperative subcutaneous bleeding.\[[@ref4]\] Similarly, in the second study, of the 107 patients who were on anticoagulants, only one patient on clopidogrel developed a haematoma\[[@ref5]\]. Admittedly, some of these studies are retrospective in nature. However, they do show that it is likely not necessary to stop anticoagulation prior to hand surgery (as long as INR is within therapeutic range in the case of Warfarin). Furthermore, with the lack of clear guidelines from the British Society for Surgery of the Hand, the surgeon is often left to weigh up the risks of peri- or post-operative bleeding against a potentially life-threatening thrombotic event. It is suggested that a randomised control trial or more adequately powered prospective study be conducted to determine the risk of peri- or post-operative bleeding as a result of anticoagulant therapy and to formulate definitive guidelines relating to this subject. However, it would also seem that the current evidence suggests that anticoagulant therapy need not be halted on a routine basis for such surgeries.
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